Chinese Medical Association updates lung cancer diagnosis and treatment guideline for 2026
The 2026 Chinese lung cancer guideline adds AI and opportunistic screening in low-dose CT, expands molecular testing, and updates treatment regimens for NSCLC, including perioperative, consolidation immunotherapy, and targeted therapy for EGFR, ALK, KRAS, HER2, and MET alteratio…